Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5362799

CC[N+]1(CCO)CCCN(c2ccc(N)c(C)c2)CC1.[Cl-]

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.49
RAD52 P43351 1/20 0.49
CHRNA10 Q9GZZ6 11/20 0.41
CHRNA9 Q9UGM1 11/20 0.41
CHRNA7 P36544 9/20 0.41
S100B P04271 2/20 0.36
MEN1 O00255 2/20 0.36
LMNA P02545 2/20 0.36
KMT2A Q03164 2/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
ALOX15 P16050 1/20 0.36
MAPK1 P28482 1/20 0.36
HTT P42858 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
IP6K1 Q92551 1/20 0.36
LGMN Q99538 1/20 0.34
TNNI3 P19429 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746050 0.99 GAA (0.50) GAARAD52CHRNA10CHRNA9CHRNA7
Hydrochloric Acid SCHEMBL5345795 0.95 GAA (0.53) GAARAD52CHRNA10CHRNA9CHRNA7
Hydrochloric Acid SCHEMBL5397681 0.94 GAA (0.49) GAARAD52CHRNA10CHRNA9CHRNA7
SCHEMBL6746574 0.94 GAA (0.55) GAARAD52CHRNA10CHRNA9CHRNA7
SCHEMBL6748617 0.93 GAA (0.50) GAARAD52CHRNA10CHRNA9CHRNA7
Hydrochloric Acid SCHEMBL5346509 0.89 GAA (0.54) GAARAD52CHRNA10CHRNA9CHRNA7
SCHEMBL14559154 0.88 GAA (0.55) GAARAD52CHRNA10CHRNA9CHRNA7
Hydrochloric Acid SCHEMBL5352676 0.84 CHRNA10 (0.48) GAARAD52CHRNA10CHRNA9CHRNA7
Hydrochloric Acid SCHEMBL5403739 0.83 GAA (0.48) GAARAD52CHRNA10CHRNA9S100B
SCHEMBL6742112 0.83 CHRNA10 (0.49) GAARAD52CHRNA10CHRNA9CHRNA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7186277-B2 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL SA (FR) 2007-03-06 US claimed
US-20040237216-A1 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL S.A. (FR) 2004-12-02 US claimed
US-7186277-B2 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring L'OREAL SA (FR) 2007-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040237216-A1 Composition for dyeing keratin fibres, comprising a cationic para-phenylenediamine derivative substituted with a diazacyclohexane or diazacycloheptane ring KRT18, CDC73, DSP GAA 4807/4885RAD52 651/4885CHRNA10 898/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.